Overview

A Study to Investigate the PK and Safety of CKD-393

Status:
Completed
Trial end date:
2021-04-27
Target enrollment:
Participant gender:
Summary
A clinical trial to investigate the pharmacokinetics and safety after oral administration of CKD-393
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical